CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC was delisted on the 23rd of June, 2023.
95 hedge funds and large institutions have $96.6M invested in CTI BioPharma Corp. (DE) Common Stock in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 17 closing their positions.
910% more call options, than puts
Call options by funds: $2.32M | Put options by funds: $230K
65% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 23
3% less funds holding
Funds holding: 98 → 95 (-3)
13% less capital invested
Capital invested by funds: $110M → $96.6M (-$13.9M)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$5.34M |
| 2 |
Jane Street
New York
|
+$2.56M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.33M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.21M |
| 5 |
PCM
Pyrrho Capital Management
New York
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$16.3M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$7.84M |
| 3 |
Millennium Management
New York
|
-$7.42M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.76M |
CTIC Hedge Fund Activity: Q2 2015 in Review
95 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q2 2015, worth a combined $96.6M — down 13% from $110M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CTIC and 14 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 38 added.
The largest buyer was Lombard Odier Asset Management (USA), opening a new position worth an estimated $5.34M. The largest seller was State Street, cutting an estimated $16.3M.
- 95 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q2 2015, down from 98 in Q1 2015.
- Funds reported $96.6M of CTI BioPharma Corp. (DE) Common Stock stock for Q2 2015, down 13% quarter-over-quarter.
- 14 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q2 2015 and 17 closed out, a net change of -3 holders.
- The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q2 2015 was Lombard Odier Asset Management (USA), an estimated $5.34M added.
- The largest CTI BioPharma Corp. (DE) Common Stock seller in Q2 2015 was State Street, an estimated $16.3M sold.
Based on aggregated 13F filings for Q2 2015.